No Data
No Data
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to Its Scientific Advisory Board
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Salarius Pharmaceuticals Merger Partner Announces Series of Drug Candidates
Salarius Pharmaceuticals Advances Merger With Decoy Therapeutics to Enhance Development of Innovative Cancer and Viral Therapeutics
Salarius Pharmaceuticals Reports FY24 EPS ($5.79) Vs. ($30.74) Last Year
Salarius Pharmaceuticals Sees Cash Runway Through Later Part of 2Q25
Den the Dragon : nice